The Essential Goods and Supply Chain Program is playing a vital role in Queensland’s economic recovery strategy. Learn more about the Queensland companies that have joined the global pandemic response and have helped Queensland’s ability to respond to COVID-19 and be prepared for future pandemics.
Thanks to funding from the Essential Goods and Supply Chain Program, Brisbane company AnteoTech is one step closer to delivering an innovative point-of-care rapid COVID-19 test.
The funding will progress the high-sensitivity and low-cost test from prototype through to manufacturing and product launch subject to successful clinical trials and regulatory approvals.
The high-sensitivity COVID-19 Antigen Rapid Test (ART) will aim to deliver results in just 15 minutes.
The COVID-19 ART is based on AnteoTech’s proprietary binding technology coupled with global advancements in assay detection systems which provides valuable decision-making support for the early detection and isolation of infected patients.
By product launch Anteotech will have built capacity to produce a large volume of tests at its facility at Eight Mie Plains, and the project is expected to create up to 5 new high-skilled jobs and protect 20 existing jobs.
The Advanced Robotics for Manufacturing (ARM) Hub will work with two Queensland businesses with support from the Essential Goods and Supply Chain Program. The north Brisbane based not-for-profit is a world leading technology centre in robotics and design led manufacturing.
The ARM Hub will work with Spinal Life Australia and Consolidated Linen Service to develop effective robotics and advanced manufacturing technologies for use in response to the impacts of COVID-19. Spinal Life Australia’s project will focus on developing remote care solutions for people with spinal injuries, and Consolidated Linen Service’s project will develop automated laundry solutions to reduce worker exposure to infectious diseases.
The $18 million ARM Hub is a joint initiative of industry, the Innovative Manufacturing CRC, CSIRO, QUT and the Queensland Government.
Belgotex Fabrics is based in Acacia Ridge and is Queensland’s only major textile manufacturer.
With an increasing demand for locally made fabric for PPE production, funding from the Essential Goods and Supply Chain Program will assist the company to import and install special looms to weave special-grade fabrics and upskill its workforce.
Local PPE manufacturers will use the lightweight, tight-weave fabric to make essential items including medical scrubs uniforms, hospital linen, sheeting and privacy screens and even reusable face masks and gowns for frontline health workers.
Tingalpa-based Crystalaid will gain the relevant certification needed to produce medical devices including ventilators.
The 70-year-old Queensland micro-electronics company is part of the Grabbas Group and currently employs 42 staff, with 20 involved in hands-on manufacturing.
Crystalaid originally focused on medical device manufacture and is best known for manufacturing the Cochlear device up until the mid-2000s.
The company will use funding from the Essential Goods and Supply Chain Program to gain the relevant certification needed to produce medical devices including ventilators.
The Essential Goods and Supply Chain Program is providing funding to Brisbane-based biotech company Ellume to introduce advanced manufacturing processes to speed up and enhance production capability of its rapid COVID-19 testing kit. The first of its kind in the world, the at-home blood test can detect COVID-19 within 20 minutes.
The diagnostic testing technology was created in Queensland and is being manufactured at Ellume’s new facility in Richlands. The funding assisted the company to install state-of-the-art automated production lines to assemble the tests for export.
Following approval from the US Food and Drug Administration, Ellume began shipments in January 2021 and plans to expand exports to Europe following the appropriate approvals.
With production currently ramping up to more than 200,000 testing kits a day, when at full capacity the facility will support more than 500 jobs and will be capable of producing 10 million tests a month.
Assistance from the Essential Goods and Supply Chain Program allowed Logan-based Flowtech to expand its business to provide PPE testing and certification.
A leader in certifying clean rooms and hospital operating theatres, the company now has the capabilities to test and certify the surgical face masks made by local manufacturers.
Prior to COVID-19, only 5% of Australia’s medical masks were made domestically. The start of local face mask manufacture required testing facilities that could provide National Association of Testing Authorities certification. Flowtech’s unique air-conditioning compliance skills were well-suited to pivot to include PPE.
Logan manufacturer Imaging Solutions will expand local testing, manufacturing and production of essential personal protective equipment (PPE) for imaging diagnostic procedures thanks to support from the Essential Goods and Supply Chain Program.
With funding it will expand existing manufacturing capacity, enhance testing facilities via adoption of new-to-Australia capability and introduce new innovative technology to support the local manufacturing of the core materials needed to produce its range of specialised PPE products.
As well as contributing towards keeping critical essential health workers safe, the funding will support 12 new local jobs and reduce reliance on imported PPE imaging products.
Support from the Essential Goods and Supply Chain Program will assist MCP Australia to accelerate production of critical personal protective equipment. Building upon existing expertise in fabric and textile fabrication, the Logan City-based manufacturer will begin manufacturing essential niche face mask products.
Products will include masks for children and masks with visors and anti-fog measures. These products are not manufactured elsewhere in Australia and are much needed on the healthcare front line. The program will also assist MCP to automate face mask packaging and to start local production of disposable medical gowns, headwear and shoe covers.
In addition to creating 40 new jobs, the program will help deliver expanded and upgraded capabilities, including the purchase and installation of new equipment.
WearOptimo will establish a Queensland facility to produce world-leading, lifesaving wearable medical technology.
The facility will be the first of its kind in Australia and will manufacture ‘sticker-like’ MicrowearableTM sensors for domestic and global distribution. The health devices are inexpensive, painless and give fast and accurate results in real-time. The new technology deployed across a range of sensors can detect dehydration, could replace frequent blood testing for various diseases, and help with the early detection of heart attacks and cardiovascular disease.
WearOptimo expects more than 90 direct, high-value jobs will be created over the next five years with the potential for many more in the future.
Last updated: Tuesday, Apr 27, 2021